Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F WRIGHT

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
British Journal of Haematology|December 3, 1999
Characterization of platelet glycoproteins and platelet/endothelial cell antibodies in patients with thrombotic thrombocytopenic purpuraJ F Wright, H Wang, A Hornstein, et al.
Gene Therapy|December 4, 2009
High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiencyE Ayuso, F Mingozzi, J Montane, et al.
Neurology|October 16, 2009
Safety and tolerability of putaminal AADC gene therapy for Parkinson diseaseC W Christine, P A Starr, P S Larson, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
British Journal of Haematology|December 3, 1999
Characterization of platelet glycoproteins and platelet/endothelial cell antibodies in patients with thrombotic thrombocytopenic purpuraJ F Wright, H Wang, A Hornstein, et al.
Gene Therapy|December 4, 2009
High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiencyE Ayuso, F Mingozzi, J Montane, et al.
Neurology|October 16, 2009
Safety and tolerability of putaminal AADC gene therapy for Parkinson diseaseC W Christine, P A Starr, P S Larson, et al.
Pageof 5